Pharma industry bets on AI to cut costs and timelines; scaling beyond pilots
A Reuters factbox says the pharmaceutical sector is betting on AI to cut costs and timelines. An industry analysis says data readiness in fragmented clinical environments is the main constraint on scaling pilots.
Who is affected and how
- pharmaceuticals
- When scaling AI pilots, data readiness should be scored together with business value.
Sources
- THERMO FISHER SCIENTIFIC | Factbox: Pharma sector doubles down on AI to slash costs, timelinesstockopedia.com · Oct 19, 2026
- Pharma sector doubles down on AI to slash costs, timelinesreuters · Oct 22, 2026
- Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development | Applied Clinical Trials Onlineappliedclinicaltrialsonline.com · Oct 22, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.